Noriyuki Kasahara

Affiliations: 
University of Southern California, Los Angeles, CA, United States 
Area:
Molecular Biology, Genetics, Microbiology Biology, Oncology
Google:
"Noriyuki Kasahara"

Children

Sign in to add trainee
Christopher R. Logg grad student 2002 USC
Harris S. Soifer grad student 2002 USC
Chien-Kuo Tai grad student 2002 USC
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Isoda L, Sonoda-Fukuda E, Fujino H, et al. (2023) Therapeutic Efficacy of Prodrug Activator Gene Therapy Using Retroviral Replicating Vectors for Human Ovarian Cancer. Anticancer Research. 43: 5311-5317
Fujino H, Sonoda-Fukuda E, Isoda L, et al. (2023) Retroviral Replicating Vectors Mediated Prodrug Activator Gene Therapy in a Gastric Cancer Model. International Journal of Molecular Sciences. 24
Kushiya H, Hiraoka K, Suzuki T, et al. (2022) Retroviral Replicating Vector Toca 511 () for Prodrug Activator Gene Therapy of Lung Cancer. Cancers. 14
Collins SA, Shah AH, Ostertag D, et al. (2021) Clinical development of retroviral replicating vector Toca 511 for gene therapy of cancer. Expert Opinion On Biological Therapy
Montoya ML, Kasahara N, Okada H. (2020) Introduction to immunotherapy for brain tumor patients: challenges and future perspectives. Neuro-Oncology Practice. 7: 465-476
Chen SH, Sun JM, Chen BM, et al. (2020) Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model. International Journal of Molecular Sciences. 21
Inagaki A, Takahashi M, Kamijima S, et al. (2019) Stem-24. Therapeutic Approach Of Stem Cell Carrying Retroviral Replicating Vectors In Human Glioma Model Neuro-Oncology. 21
Collins S, Kamath P, Matsuura S, et al. (2019) Therapeutic efficacy of vocimagene amiretrorepvec (Toca 511) prodrug activator gene therapy in peritoneal carcinomatosis models of ovarian cancer Gynecologic Oncology. 154: e29-e30
Kubo S, Takagi-Kimura M, Tagawa M, et al. (2018) Dual-vector prodrug activator gene therapy using retroviral replicating vectors. Cancer Gene Therapy
Kubo S, Takagi-Kimura M, Kasahara N. (2018) Efficient tumor transduction and antitumor efficacy in experimental human osteosarcoma using retroviral replicating vectors. Cancer Gene Therapy
See more...